Developments in dosing aids and adherence devices for glaucoma therapy: current and future perspectives

References

• Quigley HA. Number of people with glaucoma worldwide. Br. J. Ophthalmol.80, 389–393 (1996).
   PubMed Web of Science ®Google Scholar
• Goldberg I. How common is glaucoma worldwide? In: Glaucoma in the 21st Century. Weinreb RN, Kitazawa Y, Krieglstein G (Eds). Harcourt Health Communications, London, UK, 3–8 (2000).
   Google Scholar
• Kass MA, Heuer DK, Higginbotham EJ et al. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch. Ophthalmol.120, 701–713 (2002).
   PubMed Web of Science ®Google Scholar
• Leske MC, Heijl A, Hussein M et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch. Ophthalmol.121, 48–56 (2003).
   PubMed Web of Science ®Google Scholar
• Gurwitz JH, Glynn RJ, Monane M et al. Treatment for glaucoma: adherence by the elderly. Am. J. Public Health83, 711–716 (1993).
   PubMed Web of Science ®Google Scholar
• Norell SE, Granstrom PA. Self-medication with pilocarpine among outpatients in a glaucoma clinic. Br. J. Ophthalmol.64, 137–141 (1980).
   PubMed Web of Science ®Google Scholar
• Kass MA, Meltzer DW, Gordon M et al. Compliance with topical pilocarpine treatment. Am. J. Ophthalmol.101, 515–523 (1986).
   PubMed Web of Science ®Google Scholar
• Kass MA, Gordon M, Morley RE Jr, Meltzer DW, Goldberg JJ. Compliance with topical timolol treatment. Am. J. Ophthalmol.103, 188–193 (1987).
   PubMed Web of Science ®Google Scholar
• Schwartz GF. Compliance and persistency in glaucoma follow-up treatment. Curr. Opin. Ophthalmol.16, 114–121 (2005).
   PubMedGoogle Scholar
• Tsai JC, McClure CA, Ramos SE et al. Compliance barriers in glaucoma: a systematic classification. J. Glaucoma12, 393–398 (2003).
   PubMed Web of Science ®Google Scholar
• Rotchford AP, Murphy KM. Compliance with timolol treatment in glaucoma. Eye12, 234–236 (1998).
   PubMed Web of Science ®Google Scholar
• Patel SC, Spaeth GL. Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg.26, 233–236 (1995).
   PubMedGoogle Scholar
• Deokule S, Sadiq S, Shah S. Chronic open angle glaucoma: patient awareness of the nature of the disease, topical medication, compliance and the prevalence of systemic symptoms. Ophthalmic Physiol. Opt.24, 9–15 (2004).
   PubMedGoogle Scholar
• Winfield AJ, Jessiman D, Williams A, Esakowitz L. A study of the causes of non-compliance by patients prescribed eyedrops. Br. J. Ophthalmol.74, 477–480 (1990).
   PubMed Web of Science ®Google Scholar
• Brown MM, Brown GC, Spaeth GL. Improper topical self-administration of ocular medication among patients with glaucoma. Can. J. Ophthalmol.19, 2–5 (1984).
   PubMed Web of Science ®Google Scholar
• Garber MC, Nau DP, Erickson SR, Aikens JE, Lawrence JB. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med. Care42, 649–652 (2004).
   PubMed Web of Science ®Google Scholar
• Robin AL, Covert D. Does adjunctive glaucoma therapy affect adherence to the initial primary therapy? Ophthalmology112, 863–868.
   PubMedGoogle Scholar
• Buller AJ, Morgan LH, Hercules BL. Patients prefer once-daily glaucoma drops. Graefes Arch. Clin. Exp. Ophthalmol. DOI: 10.1007/s00417-006-0333-3 (2006) (Epub ahead of print).
   Google Scholar
• Bartlett SJ, Lukk P, Butz A, Lampros-Klein F, Rand CS. Enhancing medication adherence among inner-city children with asthma: results from pilot studies. J. Asthma39, 47–54 (2002).
   PubMed Web of Science ®Google Scholar
• MacLaughlin EJ, Raehl CL, Treadway AK, Sterling TL, Zoller DP, Bond CA. Assessing medication adherence in the elderly: which tools to use in clinical practice? Drugs Aging2, 231–255 (2005).
   Google Scholar
• Matsuyama JR, Mason BJ, Jue SG. Pharmacists’ interventions using an electronic medication-event monitoring device’s adherence data versus pill counts. Ann. Pharmacother.27, 851–855 (1993).
   PubMed Web of Science ®Google Scholar
• Julius SM, Sherman JM, Hendeles L. Accuracy of three electronic monitors for metered-dose inhalers. Chest121, 871–876 (2002).
   PubMed Web of Science ®Google Scholar
• Rivers PH. Compliance aids – do they work? Drugs Aging2, 103–111 (1992).
   PubMed Web of Science ®Google Scholar
• Averns H, Hall J, Webley M. Role of opticare eye drop delivery system in patients with rheumatoid arthritis. Rheumatology26, 2615–2618 (1999).
   Google Scholar
• Laster SF, Martin JL, Fleming JB. The effect of a medication alarm device on patient compliance with topical pilocarpine. J. Am. Optom. Assoc.67, 654–658 (1996).
   PubMedGoogle Scholar
• Boden C, Sit A, Weinreb RN. Accuracy of an electronic monitoring and reminder device for use with travoprost eye drops. J. Glaucoma.15, 30–34 (2006).
   PubMed Web of Science ®Google Scholar
• Cronin TH, Kahook MY, Lathrop KL, Noecker RJ. Accuracy and performance of a commercially available dosing aid. Br. J. Ophthalmol. DOI: 10.1136/bjo.2006.103093 (2006) (Epub ahead of print).
   PubMedGoogle Scholar
• Kharod BV, Johnson PB, Nesti HA, Rhee DJ. Effect of written instructions on accuracy of self-reporting medication regimen in glaucoma patients. J. Glaucoma.15, 244–247 (2006).
   PubMed Web of Science ®Google Scholar
• Lim LL, Smith JR, Rosenbaum JT. Retisert (Bausch & Lomb/Control Delivery Systems). Curr. Opin. Investig. Drugs6(11), 1159–1167 (2005).
   PubMedGoogle Scholar
• Musch DC, Martin DF, Gordon JF, Davis MD, Kuppermann BD. Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study Group. N. Engl. J. Med.337(2), 83–90 (1997).
   PubMed Web of Science ®Google Scholar